
zzso targeted zzso therapies are now available that have been rationally designed to interact with specific proteins associated with zzso development or zzso The main purpose of this article is to review the rationale and phase zzso clinical data for approved and emerging zzso agents used in the treatment of solid zzso zzso zzso zzso and zzso have all produced advances in the treatment of the indications for which they are licensed and show promising activity in other zzso zzso Newer zzso agents in development appear, from preliminary phase I and II data, to be active in a broad range of zzso types, although the clinical relevance of this activity is as yet zzso The challenge for the future is to ensure that the potential of zzso agents is zzso by selecting the patient populations most likely to derive clinical benefit, by zzso the dose schedules used, and by investigating zzso therapies combined with other agents of the same type or with conventional chemotherapy and/or other treatment zzso 

